Venlafaxine extended release

DRUG6 trials

Sponsors

New York State Psychiatric Institute, Eli Lilly and Company, H. Lundbeck A/S, Institut National de la Santé Et de la Recherche Médicale, France

Conditions

DepressionDepressive DisorderMajor Depressive DisorderMajor Depressive Episode

Phase 2

Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder

TerminatedNCT00766870

H. Lundbeck A/SMajor Depressive Disorder

Start: 2008-09-30End: 2009-02-28Updated: 2010-09-29

Phase 3

Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries

CompletedNCT01571453

H. Lundbeck A/SMajor Depressive Disorder

Start: 2012-05-31Updated: 2014-10-13

Phase 4

Duloxetine vs. Active Comparator for the Treatment of Depression

CompletedNCT00067912

Eli Lilly and CompanyDepression

Start: 2003-04-30End: 2004-03-31Target: 480Updated: 2007-05-21

Duloxetine vs. Active Comparator in the Treatment of Patients With Depression

CompletedNCT00071695

Eli Lilly and CompanyDepression

Start: 2003-07-31End: 2004-05-31Target: 320Updated: 2007-05-21

Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)

CompletedNCT02051413

Institut National de la Santé Et de la Recherche Médicale, FranceMajor Depressive Disorder, Major Depressive Episode

Start: 2014-02-18End: 2018-05-31Updated: 2025-09-02

Unknown Phase

Improving Retention of Hispanics Receiving Antidepressant Therapy

CompletedNCT00057642

New York State Psychiatric InstituteDepression, Depressive Disorder

Start: 2002-09-30End: 2006-08-31Updated: 2013-08-20

Related Papers

White matter hyperintensities and their role in major depressive episodes: a cross-sectional study in adults under 65.

2024-12-28

Successfully treated patients with vortioxetine versus venlafaxine: a simplified cost-effectiveness analysis based on a head-to-head study in Asian patients with major depressive disorder

Current Medical Research and Opinion2020-01-288 citations

Pharmacokinetics and Safety of Vortioxetine in the Chinese Population

Advances in Therapy2019-09-2410 citations

Comparison of vortioxetine versus venlafaxine XR in adults in Asia with major depressive disorder: a randomized, double-blind study.

2015-02-1937 citations

Application of the Gradient Boosted method in randomised clinical trials: Participant variables that contribute to depression treatment efficacy of duloxetine, SSRIs or placebo.

2014-06-0414 citations